Starlight Therapy in Palliative Care

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorNova Scotia Health Authority

About this trial

Starlight Therapy™ has been shown to help alleviate end-of-life symptoms in Palliative Care patients and reduce the need for PRN or "as needed" medications. This study will investigate the efficacy of this intervention on the symptom of anxiety using a mixed-method analysis.

The primary investigator hypothesizes that any anti-anxiolytic effects could be caused by the Intrinsically Photosensitive Retinal Ganglion Cell neural pathway to the amygdala.

Eligibility criteria

Qualifiers

Insomnia

Anxiety

Restlessness

Dyspnea

Disqualifiers

Clinical Diagnosis of blindness

Insomnia

Anxiety

Restlessness

Trial design

Treatments tested in this trial

  • Starlight Therapy

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators